Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT05961085

Incidence of Adductor Canal Catheter Dislodgment

Positioning of Continuous Adductor Canal Catheters After Total Knee Arthroplasty

Status
Active Not Recruiting
Phase
Study type
Observational
Enrollment
100 (estimated)
Sponsor
Sunnybrook Health Sciences Centre · Academic / Other
Sex
All
Age
50 Years
Healthy volunteers
Not accepted

Summary

The goal of this observational study is to determine the incidence of dislodgement for adductor canal catheters after total knee arthroplasty on post-operative day 1. We will also attempt to identify factors associated with secondary catheter failure.

Detailed description

Total knee arthroplasty (TKA) is a common procedure for indications including osteoarthritis and malignancy involving the knee, with over 55,285 knee replacements performed between 2020-2021 in Canada. Ultrasound guided continuous adductor canal block (cACB) is the standard of care for postoperative analgesia for this procedure. The catheter is not always as effective at providing analgesia as would be expected - which could be due to displacement of the catheter. This displacement is most likely to occur peri-operatively or during physiotherapy post-operatively and as such, post-operative assessments can provide useful insight into causes of secondary failure. This prospective observational study aims to estimate the cACB dislodgment on POD 1 rate at a high volume, tertiary care referral centre, and identify factors associated with dislodgement and clinical sequelae. As this is an observational/QI study of the current standard of care at Sunnybrook Health Sciences Centre, anesthesiologists are free to use the cross sectional versus parallel insertion of the cACB per their discretion.

Conditions

Interventions

TypeNameDescription
PROCEDUREAdductor Canal CatheterUltrasound guided Adductor Canal Catheter for total knee arthroplasty analgesia

Timeline

Start date
2023-07-10
Primary completion
2025-12-01
Completion
2025-12-01
First posted
2023-07-27
Last updated
2025-09-12

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT05961085. Inclusion in this directory is not an endorsement.